Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CinnaPoietin versus Eprex for anemia in ESRD hemodialysis patients
IRCT201601156135N6Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes, Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of epoetin beta and epoetin alfa in anemia of chronic kidney disease and chronic kidney disease (CKD) (2 arms), sponsored by CinnaGen. Started Mar 2016; status: completed.
02
Drugs
epoetin betaepoetin alfa
03
Conditions
anemia of chronic kidney diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT201601156135N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201601156135N6.